Effects of Vitreomacular Adhesion on Age-Related Macular Degeneration
Herein, we review the association between vitreomacular adhesion (VMA) and neovascular age-related macular degeneration (AMD). Meta-analyses have shown that eyes with neovascular AMD are twice as likely to have VMA as normal eyes. VMA in neovascular AMD may induce inflammation, macular traction, dec...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2015/865083 |
id |
doaj-81d4659bb23a40b38fa00ff563b56b10 |
---|---|
record_format |
Article |
spelling |
doaj-81d4659bb23a40b38fa00ff563b56b102020-11-24T21:00:34ZengHindawi LimitedJournal of Ophthalmology2090-004X2090-00582015-01-01201510.1155/2015/865083865083Effects of Vitreomacular Adhesion on Age-Related Macular DegenerationEui Chun Kang0Hyoung Jun Koh1Department of Ophthalmology, Institute of Vision Research, Yonsei University College of Medicine, Seoul 120-752, Republic of KoreaDepartment of Ophthalmology, Institute of Vision Research, Yonsei University College of Medicine, Seoul 120-752, Republic of KoreaHerein, we review the association between vitreomacular adhesion (VMA) and neovascular age-related macular degeneration (AMD). Meta-analyses have shown that eyes with neovascular AMD are twice as likely to have VMA as normal eyes. VMA in neovascular AMD may induce inflammation, macular traction, decrease in oxygenation, sequestering of vascular endothelial growth factor (VEGF), and other cytokines or may directly stimulate VEGF production. VMA may also interfere with the treatment effects of anti-VEGF therapy, which is the standard treatment for neovascular AMD, and releasing VMA can improve the treatment response to anti-VEGF treatment in neovascular AMD. We also reviewed currently available methods of relieving VMA.http://dx.doi.org/10.1155/2015/865083 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Eui Chun Kang Hyoung Jun Koh |
spellingShingle |
Eui Chun Kang Hyoung Jun Koh Effects of Vitreomacular Adhesion on Age-Related Macular Degeneration Journal of Ophthalmology |
author_facet |
Eui Chun Kang Hyoung Jun Koh |
author_sort |
Eui Chun Kang |
title |
Effects of Vitreomacular Adhesion on Age-Related Macular Degeneration |
title_short |
Effects of Vitreomacular Adhesion on Age-Related Macular Degeneration |
title_full |
Effects of Vitreomacular Adhesion on Age-Related Macular Degeneration |
title_fullStr |
Effects of Vitreomacular Adhesion on Age-Related Macular Degeneration |
title_full_unstemmed |
Effects of Vitreomacular Adhesion on Age-Related Macular Degeneration |
title_sort |
effects of vitreomacular adhesion on age-related macular degeneration |
publisher |
Hindawi Limited |
series |
Journal of Ophthalmology |
issn |
2090-004X 2090-0058 |
publishDate |
2015-01-01 |
description |
Herein, we review the association between vitreomacular adhesion (VMA) and neovascular age-related macular degeneration (AMD). Meta-analyses have shown that eyes with neovascular AMD are twice as likely to have VMA as normal eyes. VMA in neovascular AMD may induce inflammation, macular traction, decrease in oxygenation, sequestering of vascular endothelial growth factor (VEGF), and other cytokines or may directly stimulate VEGF production. VMA may also interfere with the treatment effects of anti-VEGF therapy, which is the standard treatment for neovascular AMD, and releasing VMA can improve the treatment response to anti-VEGF treatment in neovascular AMD. We also reviewed currently available methods of relieving VMA. |
url |
http://dx.doi.org/10.1155/2015/865083 |
work_keys_str_mv |
AT euichunkang effectsofvitreomacularadhesiononagerelatedmaculardegeneration AT hyoungjunkoh effectsofvitreomacularadhesiononagerelatedmaculardegeneration |
_version_ |
1716779385918324736 |